DURECT Corporation (DRRX) Announces Third Quarter 2009 Financial Results
10/30/2009 10:58:54 AM
More...
|
DURECT Corporation (DRRX) to Participate in Upcoming Healthcare Conferences
9/17/2009 12:16:43 PM
More...
|
DURECT Corporation (DRRX) (JOBS) Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million
9/11/2009 6:56:17 AM
More...
|
DURECT Corporation (DRRX) (JOBS) Signs Long Term Excipient Supply Agreement With King Pharmaceuticals®, Inc. for REMOXY(R)
8/27/2009 6:39:11 AM
More...
|
DURECT Corporation (DRRX) to Present at the BMO Capital Markets Healthcare Conference
7/29/2009 9:28:50 AM
More...
|
DURECT Corporation (DRRX) Invites You to Join Its Second Quarter 2009 Earnings Conference Call
7/28/2009 9:43:18 AM
More...
|
DURECT Corporation (DRRX) REMOXY(R) NDA Update
7/7/2009 9:40:33 AM
More...
|
DURECT Corporation (DRRX) Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
6/17/2009 9:10:34 AM
More...
|
DURECT Corporation (DRRX) Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
3/16/2009 7:12:50 AM
More...
|
Endo Pharmaceuticals (ENDP) (JOBS) Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT Corporation (DRRX)
2/27/2009 7:08:49 AM
More...
|
|